ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $114,364 | -69.5% | 15,413 | -61.1% | 0.00% | -100.0% |
| Q1 2023 | $374,872 | +1649.4% | 39,669 | +1871.6% | 0.00% | – |
| Q4 2022 | $21,428 | -96.0% | 2,012 | -97.2% | 0.00% | -100.0% |
| Q3 2022 | $533,000 | +149.1% | 72,256 | +62.5% | 0.00% | – |
| Q2 2022 | $214,000 | +234.4% | 44,471 | +252.7% | 0.00% | – |
| Q1 2022 | $64,000 | +966.7% | 12,607 | +1086.0% | 0.00% | – |
| Q4 2021 | $6,000 | -81.8% | 1,063 | -75.8% | 0.00% | – |
| Q1 2021 | $33,000 | -86.9% | 4,385 | -86.4% | 0.00% | – |
| Q4 2020 | $252,000 | +869.2% | 32,264 | +1090.1% | 0.00% | – |
| Q3 2020 | $26,000 | – | 2,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Interchange Capital Partners, LLC | 11,420 | $90,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 47,097 | $373,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $80,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 99,166 | $784,000 | 0.01% |
| EMFO, LLC | 1,666 | $13,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 34,333 | $272,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 51,466 | $407,000 | 0.00% |
| Tarbox Family Office, Inc. | 332 | $3,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,808 | $30,000 | 0.00% |